<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04038255</url>
  </required_header>
  <id_info>
    <org_study_id>20190328</org_study_id>
    <nct_id>NCT04038255</nct_id>
  </id_info>
  <brief_title>Mindfulness Based Smoking Cessation Among Cancer Survivors</brief_title>
  <official_title>Smartphone Application Versus In-person Mindfulness-based Smoking Cessation Intervention for Young Cancer Survivors: Reach Versus Effectiveness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the effect of a mindfulness-based smoking cessation program among
      cancer survivors.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 28, 2019</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with confirmed smoking abstinence</measure>
    <time_frame>3 months</time_frame>
    <description>self-report of not smoking in the past 7-days, not even a puff, confirmed by expired carbon monoxide (CO) level of &lt; 10 ng/ml</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in number of cigarettes smoked per day</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <description>Self-reported number of cigarettes smoked per day by each participant (Question is: On average, how many cigarettes do you smoke per day?)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with reported relapse</measure>
    <time_frame>3 months</time_frame>
    <description>Relapse is defined as smoking at least once/week on two consecutive weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability of the Craving-to-Quit app as assessed by the number of times participant logged in the app</measure>
    <time_frame>3 months</time_frame>
    <description>How usable participants found the app measured by the absolute number of times logged into the app.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability of the Craving-to-Quit app as assessed by the number of days of completed app use</measure>
    <time_frame>3 months</time_frame>
    <description>How usable participants found the app measured by self-reported number of completed days for the app.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability of the Craving-to-Quit app as assessed by the comfortability with the app</measure>
    <time_frame>3 months</time_frame>
    <description>How usable participants found the app measured by the comfortability of the app via questionnaire with scores ranging from 0-10 with the higher score indicating increased comfortability with the app.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acceptability</measure>
    <time_frame>3 months</time_frame>
    <description>Assessed by 3 items &quot;How satisfied were you with the intervention?&quot;, &quot;How likely are you to recommend this intervention to a friend?&quot; and &quot;How useful was the intervention?&quot; Each question is scored from 0-10 with the higher score indicating increased acceptability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility of recruitment as assessed via enrollment rate</measure>
    <time_frame>Baseline</time_frame>
    <description>A feasible recruitment is defined as an enrollment rate of 70% or higher.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Attrition</measure>
    <time_frame>3 months</time_frame>
    <description>Defined as the number of participants not having a final visit at the end of treatment, categories include mortality, withdrawal from the study, transfer to non-study clinics, loss to follow-up without identifiable cause.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Tobacco Smoking</condition>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this group will receive a brief advice to quit smoking, 6-week supplies of nicotine replacement therapy (NRT), and self-help materials to quit smoking.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Craving-to-Quit app</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive one in-person orientation session, 6-week supply of NRT, the &quot;Craving-to-Quit&quot; app, and two brief follow-up phone calls.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>In-person Mindfulness Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive twice weekly group sessions (eight total during 4 weeks) that were manualized and delivered by instructors experienced in Mindfulness Training (MT) (a single therapist with &gt;4 years of training in MT).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicoderm C-Q Transdermal Product</intervention_name>
    <description>6 weeks of nicotine replacement therapy patches</description>
    <arm_group_label>Craving-to-Quit app</arm_group_label>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Orientation session</intervention_name>
    <description>This session will occur 2 weeks before quit date. It will be moderated by a certified instructor in MT, and will last approximately 90 min. During the session, participants will learn the purpose, format, and procedures of the study, provide written informed consent, and complete the baseline assessment.</description>
    <arm_group_label>Craving-to-Quit app</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Craving-to-Quit app</intervention_name>
    <description>The app is comprised of 22 modules for 22 days, 5-15 minutes each, designed to teach MT using audio, video, and animation. The app also includes other features such as social support (quit friend sign-ups, the tip of the week), activity feed (to track interaction with the app), and my morning stats (to track smoking).</description>
    <arm_group_label>Craving-to-Quit app</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Two brief follow-up phone calls</intervention_name>
    <description>The first phone call will occur one day before the quit date to remind participants about their quit date and provide support. The second will occur at the end of treatment (around day 60 after quit date) to review progress, provide support, and schedule the 3-month follow-up visit. Each phone call will last approximately 15 minutes.</description>
    <arm_group_label>Craving-to-Quit app</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Group MT sessions</intervention_name>
    <description>Total of eight group sessions (twice a week) during 4 weeks. The overarching theme of momentary awareness and acceptance of cravings and affect (e.g., stress, anxiety etc.) will be introduced and reinforced in complementary ways throughout the training. Each session will last 45-60 minutes.</description>
    <arm_group_label>In-person Mindfulness Training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Brief advice on quitting smoking</intervention_name>
    <description>Standard advice on how to quit smoking.</description>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Self-help smoking cessation materials</intervention_name>
    <description>Written materials on how to quit smoking including contact info for state tobacco quitline.</description>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be 18-40 years old (young cancer survivors)

          -  Cancer survivors (based on the NCI definition — &quot;a person is considered to be a
             survivor from the time of diagnosis until the end of life&quot; National Cancer Institute
             Dictionary of Cancer Terms, 2014)52

          -  Have smoked ≥ 5 cigarettes/day in the past year

          -  Be interested in making a quit attempt in the next 30 days

          -  Own a smartphone (apple/android)

          -  Read/speak English

          -  Able to consent

          -  Have no plans to move in the next 3 months

          -  Are not pregnant or planning to be pregnant in the following 3 months

        Exclusion Criteria:

          -  Have contraindication to NRT (past month myocardial infarction, history of serious
             arrhythmias/or unstable angina pectoris, dermatological disorder)

          -  Have cognitive/mental health impairment that inhibits mindfulness treatment

          -  Are currently in active cancer treatment

          -  Are currently being treated for smoking cessation, alcoholism, or illicit drug use

          -  Are adults unable to consent

          -  Are individuals who are not yet adults

          -  Are pregnant women

          -  Are prisoners
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Taghrid Asfar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Taghrid Asfar, MD</last_name>
    <phone>305-243-3826</phone>
    <email>tasfar@miami.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laura McClure</last_name>
    <phone>518-584-8391</phone>
    <email>lmcclure@med.miami.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura A McClure, MSPH</last_name>
      <phone>518-584-8391</phone>
      <email>lmcclure@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Taghrid Asfar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>July 26, 2019</study_first_submitted>
  <study_first_submitted_qc>July 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2019</study_first_posted>
  <last_update_submitted>November 14, 2019</last_update_submitted>
  <last_update_submitted_qc>November 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Taghrid Asfar</investigator_full_name>
    <investigator_title>Research Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>cancer</keyword>
  <keyword>nicotine replacement therapy</keyword>
  <keyword>mindfulness</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

